MaxCyte Inc (NASDAQ:MXCT) price on Thursday, July 03, fall -0.22% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.23.
A look at the stock’s price movement, the close in the last trading session was $2.24, moving within a range at $2.22 and $2.2999. The beta value (5-Year monthly) was 0.299. Turning to its 52-week performance, $5.20 and $2.00 were the 52-week high and 52-week low respectively. Overall, MXCT moved -1.97% over the past month.
MaxCyte Inc’s market cap currently stands at around $237.62 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MXCT is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend MXCT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MXCT’s current price about 1.50% and -5.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.95, while 7-day volatility ratio is 5.15% and 6.02% in the 30-day chart. Further, MaxCyte Inc (MXCT) has a beta value of 0. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -169.06% off current price level while to achieve the yearly target high, price needs to move -169.06%. Nonetheless, investors will most likely welcome a -169.06% jump to $6 which is the analysts’ median price.
If we refocus on MaxCyte Inc (NASDAQ:MXCT), historical trading data shows that trading volumes averaged 0.84 over the past 10 days and 946.47K over the past 3 months. The company’s latest data on shares outstanding shows there are 106.31 million shares.
The 8.14% of MaxCyte Inc’s shares are in the hands of company insiders while institutional holders own 74.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.56 million on 2025-06-13, giving us a short ratio of 3.02. The data shows that as of 2025-06-13 short interest in MaxCyte Inc (MXCT) stood at 337.0 of shares outstanding, with shares short falling to 3.83 million registered in 2025-05-15. Current price change has pushed the stock -41.64% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MXCT stock continues to rise going into the next quarter.
